SD
Swami Dharam
View Swami's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Adl At Calyx Chemicals And Pharmaceuticals Ltd
Present
Company Details
CALYX is an Active Pharmaceutical Ingredient manufacturer with excellent custom synthesis capabilities. √ Offers APIs and Custom Syntheses Services meeting International quality standards. √ Globally recognized as the largest supplier of Pyrazinamide, an Anti tuberculosis drug. √ Product Range includes Antitubercular, Antimalarial, Antihypertensive, Macrolides,Hypnotic, sedative, Antifungal, Antihistaminic, Antihypertensive, Antiretroviral, Antidiabetic. √ Production facilities and Custom Synthesis department designed to service the most exacting client requirements. √ Capabilities from grams to large tonnage in compliance with cGMP standards. √ Meeting US FDA, EDMF and COS norms √ Readiness to meet customer needs We look forward to partner with global players to expand our prestigious client base.
Year Founded
1979
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing, Capacity Planning Services, Business Consultant, Business Planning and Management, Business & Audit Services, Irbesartan Tablet, Blood Pressure Medicine, Cardiovascular Drugs & Medication, Drugs & Pharmaceuticals, Lumefantrine Powder
HQ Location
Navi Mumbai, Maharashtra 400703, IN
Keywords
CALYXa Niche API Manufacturer and Marketer who is having all International accreditations like USFDAEDQUMKoreaJapan (PMDA) has started its operations with a bang and ready to serve our valuable clientele. CALYX also take the opportunity to thank all our AssociatesVendorsAdvisors for their continued support and guidance for the last many years and we expect to have your continued support. Please contact us for all your requirementsCareer openingsetc.
Discover More About Cleveland Clinic

Find verified contacts of Swami Dharam in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.